- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07628413
Comparative Effects of Egoscue and Feldenkrais Exercises on in Upper Cross Syndrome
Comparative Effects of Egoscue and Feldenkrais Exercises on Pain, Craniovertebral Angle and Functional Disability in Upper Cross Syndrome
Upper cross syndrome is a common postural dysfunction that is caused due to alternating tightness and weakness in the opposite muscle groups of the neck, shoulders and upper back which results in abnormal postural deviations. The aim of the study will be to compare the effects of Egoscue exercises and Feldenkrais exercises on pain, craniovertebral angle and functional disability in upper cross syndrome.
A Randomized clinical trial will be conducted at Ghurki Trust Teaching Hospital, Lahore and Riphah clinic, Lahore through non probability convenience sampling technique on 54 patients which will be allocated using simple random sampling through sealed opaque envelop into Group A and Group B. Group A will be treated with Egoscue exercises and conventional therapy and Group B will be treated with Feldenkrais exercises and conventional therapy at the frequency of 3 sets with 10 repetitions thrice a week. Outcome measures will be conducted through pain, craniovertebral angle and functional disability after 4 weeks. Data will be analyzed with SPSS software version 26. After assessing the normality of data by Shapiro-Wilk test, it will be decided either parametric or non- parametric will be used within the group or between the groups.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: iqbal Tariq, phd
- Telefonnummer: 03338236752
- E-mail: iqbal.tariq@riphah.edu.pk
Undersøgelse Kontakt Backup
- Navn: Rabiya Noor, phd
- Telefonnummer: 03344355660
- E-mail: Rabiya.Noor@riphah.edu.pk
Studiesteder
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54000
- Rekruttering
- Rabiya Noor
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- Age 25 to 45 years
- Both genders (male and female)
- Chronic neck pain for more than three months - NPRS (3 to 7)
- Craniovertebral angle less than 50 degrees
- Tight Pectoralis muscle and trapezius
- Weak rhomboids and deep neck flexors
Exclusion Criteria:
- Any malignancy related to soft tissue and shoulder joint
- Congenital joint deformity
- Recent fractures to joint
- Recent surgery of shoulder joint or associated structures
- Patients with shoulder dislocation
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Egoscue exercises
|
|
|
Aktiv komparator: Feldenkrais exercises
|
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Disability Index (DNI)
Tidsramme: 6th week
|
This questionnaire will be used to asses disability.
It comprises of 10 items; 7 related to daily living activities; 2 related to pain and 1 related to concentration.
Each item is scored from 0 to 5. Total score is expressed as a percentage, with higher scores related to greater disability.
Minimum detectable change measurements vary from 4.2 to 13.4, and minimum clinically important differences vary from 5 and 9.5
|
6th week
|
|
Craniovertebral angle (CVA)
Tidsramme: 6th week
|
Craniovertebral angle can be measured with Image J software.
If the angle is less than 50 degrees (< 50 degree).
The angle will be between tragus of the ear to cervical spinous process C7.
|
6th week
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: areesha shakeel, MSPT(CP), Riphah International University
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- REC/RCR&AHS/25/0111
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Upper Cross Syndrome
-
GlaxoSmithKlineIkke rekrutterer endnu
-
Unravel Biosciences, Inc.RekrutteringPitt Hopkins syndromColombia
-
Helen Keller Eye Research FoundationFive Lakes Clinical Research Consulting, LLCRekrutteringStickler syndrom type 2 | Stickler syndrom type 1Forenede Stater
-
University of California, Los AngelesBoston Children's Hospital; Duke University; Children's Hospital Medical...RekrutteringBohring-Opitz syndrom | ASXL1 genmutation | Shashi-Pena syndrom | ASXL2-genmutation | Bainbridge-Ropers syndrom | ASXL3 genmutationForenede Stater
-
Neuren Pharmaceuticals LimitedRekrutteringPhelan-McDermid syndromForenede Stater
-
Neuren Pharmaceuticals LimitedRekrutteringPhelan-McDermid syndromForenede Stater
-
University of California, DavisNational Cancer Institute (NCI); Celgene; Pharmacyclics LLC.AfsluttetTidligere behandlet myelodysplastisk syndrom | Myelodysplastisk syndrom | Terapi-relateret myelodysplastisk syndrom | Sekundært myelodysplastisk syndrom | Refraktært højrisiko myelodysplastisk syndromForenede Stater
-
Riphah International UniversityAfsluttet
-
Riphah International UniversityAfsluttet
-
Shaare Zedek Medical CenterUkendtPræmenstruelt syndrom - PMS